Regarding tumor development it should be noted that E-cadherin is able to inhibit Nrf2 activity and HNF4α can block β-catenin activity [28,56], explaining partial differentiation of HLN cells; a phenomenon known from many blastemal human tumor (in particular following chemotherapy). Here, HNF4A is linked to neoplasm.